Ketamine for suicidal ideation treatment: Available evidence remains convincing

Affiliations

¹ Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy; Department of Mental Health, ASST Nord Milano, Milano, Italy. Electronic address: f.bartoli@campus.unimib.it.
² Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.
³ Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy; Department of Mental Health, ASST Nord Milano, Milano, Italy; Division of Psychiatry, University College London, London, UK.

Comment

Francesco Bartoli et al. Neurosci Biobehav Rev. 2019 Apr.

. 2019 Apr:99:1-2.

doi: 10.1016/j.neubiorev.2019.01.020. Epub 2019 Jan 22.

¹ Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy; Department of Mental Health, ASST Nord Milano, Milano, Italy. Electronic address: f.bartoli@campus.unimib.it.
² Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.
³ Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy; Department of Mental Health, ASST Nord Milano, Milano, Italy; Division of Psychiatry, University College London, London, UK.

No abstract available

Comment on

Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis.
Bartoli F, Riboldi I, Crocamo C, Di Brita C, Clerici M, Carrà G. Bartoli F, et al. Neurosci Biobehav Rev. 2017 Jun;77:232-236. doi: 10.1016/j.neubiorev.2017.03.010. Epub 2017 Mar 23. Neurosci Biobehav Rev. 2017. PMID: 28342764